A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
A Double-blind, Placebo-controlled Pilot Study to Collect and Evaluate Data on the Use of Intravenous Ibuprofen in the Treatment of an Acute Migraine
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
A Study of LY3451838 in Participants With Migraine
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
A Study to Evaluate White Matter Hyperintensities in Migraine
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention
Auricular Acupuncture vs SOC in Migraine HA
Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine
Clinical Decision Support for Patient Migraine Management
Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)
Determining the Utility of a Behavioral Intervention in Chronic Migraine
Dexamethasone for Migraine - Dose Comparison
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Efficacy of Erenumab on Functional Impact of Migraine
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
Fremanezumab, Migraine and Sleep
Galcanezumab for Vestibular Migraine
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine
Imaging the Migraine Brain Pre- and Post-Erenumab
Inflammatory Markers in Migraine - Ictally and Interictally
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients
Migraine and Homeostasis:What Can we Learn From Glucose
Migraine Manager (R01)
Mind and Body Approaches to Pain Reduction in Youth With Migraine
Mind Body Balance for Pediatric Migraine
Narrow Band Green Light and Migraine
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
Occipital Blocks for Acute Migraine
Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?
Peri-neural Electrical Dry Needling Migraine Treatment Study
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Real World Effectiveness of Eptinezumab in Participants With Migraine
Repeat Dosing of Psilocybin in Migraine Headache
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Spectacle Tints and Thin-Films for Migraine
SPG Block for Acute Pediatric Migraine
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
Study of Low-level Laser Therapy in the Acute Treatment of Migraine
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine
Telehealth Behavioral Migraine Management
Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine
Therapy for Migraine Prevention in Children 6-11 Years of Age
Treatment of Chronic Migraine Headaches.
Treatment of Tinnitus With Migraine Medications
Vagus Nerve Stimulation and Stress Reduction Training for Migraine